S&P 500   4,541.35 (-0.19%)
DOW   35,663.87 (+0.17%)
QQQ   374.01 (-0.86%)
AAPL   149.06 (-0.28%)
MSFT   309.29 (-0.47%)
FB   322.87 (-5.56%)
GOOGL   2,745.08 (-3.26%)
TSLA   904.32 (+1.15%)
AMZN   3,353.00 (-2.39%)
NVDA   228.23 (+0.58%)
BABA   177.30 (-0.07%)
NIO   38.96 (-2.53%)
CGC   13.37 (-4.77%)
GE   103.91 (+0.74%)
AMD   119.65 (+0.27%)
MU   67.49 (-1.68%)
T   25.51 (-0.97%)
F   16.38 (-1.03%)
ACB   7.09 (-3.80%)
DIS   168.83 (-1.46%)
PFE   42.82 (-0.09%)
BA   212.94 (-0.65%)
AMC   36.23 (-7.67%)
S&P 500   4,541.35 (-0.19%)
DOW   35,663.87 (+0.17%)
QQQ   374.01 (-0.86%)
AAPL   149.06 (-0.28%)
MSFT   309.29 (-0.47%)
FB   322.87 (-5.56%)
GOOGL   2,745.08 (-3.26%)
TSLA   904.32 (+1.15%)
AMZN   3,353.00 (-2.39%)
NVDA   228.23 (+0.58%)
BABA   177.30 (-0.07%)
NIO   38.96 (-2.53%)
CGC   13.37 (-4.77%)
GE   103.91 (+0.74%)
AMD   119.65 (+0.27%)
MU   67.49 (-1.68%)
T   25.51 (-0.97%)
F   16.38 (-1.03%)
ACB   7.09 (-3.80%)
DIS   168.83 (-1.46%)
PFE   42.82 (-0.09%)
BA   212.94 (-0.65%)
AMC   36.23 (-7.67%)
S&P 500   4,541.35 (-0.19%)
DOW   35,663.87 (+0.17%)
QQQ   374.01 (-0.86%)
AAPL   149.06 (-0.28%)
MSFT   309.29 (-0.47%)
FB   322.87 (-5.56%)
GOOGL   2,745.08 (-3.26%)
TSLA   904.32 (+1.15%)
AMZN   3,353.00 (-2.39%)
NVDA   228.23 (+0.58%)
BABA   177.30 (-0.07%)
NIO   38.96 (-2.53%)
CGC   13.37 (-4.77%)
GE   103.91 (+0.74%)
AMD   119.65 (+0.27%)
MU   67.49 (-1.68%)
T   25.51 (-0.97%)
F   16.38 (-1.03%)
ACB   7.09 (-3.80%)
DIS   168.83 (-1.46%)
PFE   42.82 (-0.09%)
BA   212.94 (-0.65%)
AMC   36.23 (-7.67%)
S&P 500   4,541.35 (-0.19%)
DOW   35,663.87 (+0.17%)
QQQ   374.01 (-0.86%)
AAPL   149.06 (-0.28%)
MSFT   309.29 (-0.47%)
FB   322.87 (-5.56%)
GOOGL   2,745.08 (-3.26%)
TSLA   904.32 (+1.15%)
AMZN   3,353.00 (-2.39%)
NVDA   228.23 (+0.58%)
BABA   177.30 (-0.07%)
NIO   38.96 (-2.53%)
CGC   13.37 (-4.77%)
GE   103.91 (+0.74%)
AMD   119.65 (+0.27%)
MU   67.49 (-1.68%)
T   25.51 (-0.97%)
F   16.38 (-1.03%)
ACB   7.09 (-3.80%)
DIS   168.83 (-1.46%)
PFE   42.82 (-0.09%)
BA   212.94 (-0.65%)
AMC   36.23 (-7.67%)
NASDAQ:TVTY

Tivity Health Stock Forecast, Price & News

$25.16
+0.22 (+0.88 %)
(As of 10/22/2021 01:02 PM ET)
Add
Compare
Today's Range
$24.89
$25.43
50-Day Range
$21.83
$24.48
52-Week Range
$13.23
$27.87
Volume645 shs
Average Volume389,237 shs
Market Capitalization$1.24 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.46
30 days | 90 days | 365 days | Advanced Chart
Receive TVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for Tivity Health and its competitors with MarketBeat's FREE daily newsletter.


Tivity Health logo

About Tivity Health

Tivity Health, Inc. provides fitness, nutrition, and social connection solutions. It operates through two segments: Healthcare and Nutrition. The Healthcare segment consists of SilverSneakers senior fitness, Prime Fitness and WholeHealth Living. The Nutrition segment provides weight management products and services and consists of Nutrisystem and South Beach Diet. The company was founded by Robert E. Stone and Thomas G. Cigarran in 1981 and is headquartered in Franklin, TN.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Health Care Services
Sector
Medical
Current Symbol
NASDAQ:TVTY
CUSIP
42224510
Employees
350
Year Founded
2017

Sales & Book Value

Annual Sales
$437.71 million
Cash Flow
$3.07 per share
Book Value
$0.08 per share

Profitability

Net Income
$-223.63 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.24 billion
Next Earnings Date
11/2/2021 (Confirmed)
Optionable
Optionable

Social Links


MarketRank

Overall MarketRank

2.17 out of 5 stars

Medical Sector

381st out of 1,358 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

11th out of 20 stocks

Analyst Opinion: 1.2Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 1.3 5 -4 -3 -2 -1 -












Tivity Health (NASDAQ:TVTY) Frequently Asked Questions

Is Tivity Health a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Tivity Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TVTY, but not buy additional shares or sell existing shares.
View analyst ratings for Tivity Health
or view top-rated stocks.

What stocks does MarketBeat like better than Tivity Health?

Wall Street analysts have given Tivity Health a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tivity Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Tivity Health?

Tivity Health saw a increase in short interest in September. As of September 15th, there was short interest totaling 5,330,000 shares, an increase of 19.0% from the August 31st total of 4,480,000 shares. Based on an average daily trading volume, of 390,600 shares, the days-to-cover ratio is presently 13.6 days. Currently, 12.3% of the shares of the company are short sold.
View Tivity Health's Short Interest
.

When is Tivity Health's next earnings date?

Tivity Health is scheduled to release its next quarterly earnings announcement on Tuesday, November 2nd 2021.
View our earnings forecast for Tivity Health
.

How can I listen to Tivity Health's earnings call?

Tivity Health will be holding an earnings conference call on Tuesday, November 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 416-621-4642 with passcode "4783268".

How were Tivity Health's earnings last quarter?

Tivity Health, Inc. (NASDAQ:TVTY) announced its quarterly earnings data on Wednesday, August, 4th. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.35 by $0.13. The company had revenue of $120.07 million for the quarter, compared to analysts' expectations of $112.33 million. Tivity Health had a negative net margin of 4.55% and a positive trailing twelve-month return on equity of 592.23%.
View Tivity Health's earnings history
.

How has Tivity Health's stock been impacted by Coronavirus?

Tivity Health's stock was trading at $7.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TVTY shares have increased by 219.4% and is now trading at $25.23.
View which stocks have been most impacted by COVID-19
.

What guidance has Tivity Health issued on next quarter's earnings?

Tivity Health updated its FY 2021 earnings guidance on Wednesday, September, 1st. The company provided earnings per share guidance of $1.540-$1.620 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.530. The company issued revenue guidance of $465 million-$485 million, compared to the consensus revenue estimate of $474.70 million.

What price target have analysts set for TVTY?

8 brokerages have issued twelve-month price targets for Tivity Health's stock. Their forecasts range from $20.00 to $33.00. On average, they expect Tivity Health's share price to reach $25.71 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price.
View analysts' price targets for Tivity Health
or view top-rated stocks among Wall Street analysts.

Who are Tivity Health's key executives?

Tivity Health's management team includes the following people:
  • Richard M. Ashworth, President, Chief Executive Officer & Director
  • Tommy Lewis, Chief Operating Officer & President-Nutrition
  • Adam C. Holland, Chief Financial Officer
  • Sarah Richardson, Chief Information Officer
  • Stacey Santo, Chief Experience & Innovation Officer

What is Richard Ashworth's approval rating as Tivity Health's CEO?

8 employees have rated Tivity Health CEO Richard Ashworth on Glassdoor.com. Richard Ashworth has an approval rating of 36% among Tivity Health's employees. This puts Richard Ashworth in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tivity Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include NVIDIA (NVDA), Energy Transfer (ET), Pfizer (PFE), Advanced Micro Devices (AMD), AT&T (T), (CGC), Sorrento Therapeutics (SRNE), Applied Materials (AMAT), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

What is Tivity Health's stock symbol?

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Who are Tivity Health's major shareholders?

Tivity Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include SummerHaven Investment Management LLC (0.07%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.04%), Sheets Smith Wealth Management (0.02%) and Pacifica Partners Inc. (0.00%). Company insiders that own Tivity Health stock include Anthony Michael Sanfilippo, Kevin Wills, Lee Shapiro and Sara Finley.
View institutional ownership trends for Tivity Health
.

Which major investors are selling Tivity Health stock?

TVTY stock was sold by a variety of institutional investors in the last quarter, including SummerHaven Investment Management LLC.
View insider buying and selling activity for Tivity Health
or view top insider-selling stocks.

Which major investors are buying Tivity Health stock?

TVTY stock was acquired by a variety of institutional investors in the last quarter, including Sheets Smith Wealth Management, State of Alaska Department of Revenue, Louisiana State Employees Retirement System, and Pacifica Partners Inc.. Company insiders that have bought Tivity Health stock in the last two years include Anthony Michael Sanfilippo, Kevin Wills, Lee Shapiro, and Sara Finley.
View insider buying and selling activity for Tivity Health
or or view top insider-buying stocks.

How do I buy shares of Tivity Health?

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tivity Health's stock price today?

One share of TVTY stock can currently be purchased for approximately $25.23.

How much money does Tivity Health make?

Tivity Health has a market capitalization of $1.24 billion and generates $437.71 million in revenue each year. The company earns $-223.63 million in net income (profit) each year or $1.46 on an earnings per share basis.

How many employees does Tivity Health have?

Tivity Health employs 350 workers across the globe.

When was Tivity Health founded?

Tivity Health was founded in 2017.

What is Tivity Health's official website?

The official website for Tivity Health is www.tivityhealth.com.

Where are Tivity Health's headquarters?

Tivity Health is headquartered at 701 Cool Springs Boulevard, Franklin TN, 37067.

How can I contact Tivity Health?

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at (800) 869-5311 or via email at in[email protected].


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.